INTRODUCING Angelini Pharma’s ALCAVIS Bleach – 1:10: EFFECTIVE AGAINST Clostridium difficile 

Angelini Pharma Inc., the American business arm of leading Italian pharmaceutical company Angelini, announces that the U.S. Environmental Protection Agency (EPA) approved claims for ALCAVIS Bleach Wipe’s 1:10 Dilution to be effective against Clostridium difficile (commonly referred to as C. diff).   Although, the product was effective against C. diff before, the claim “effective against C. diff” is now approved by the EPA.

C. diff is a spore-forming, Gram-positive anaerobic bacillus which the CDC says “is estimated to cause almost half a million infections per year in the United States, and 29,000 deaths within 30 days of the initial diagnosis”1.  Alcohol, general antiseptics and standard EPA-registered hospital disinfectants are not effective against C. diff.  For this reason, C. diff represents a challenge for hospital infection control practitioners in the fight to avoid Hospital-Acquired Infections.

ALCAVIS Bleach Wipes, 1:10 Dilution are approved for the disinfection of patient care equipment and hard, non-porous environmental surfaces. They were originally approved by the EPA to be effective against bacteria and organisms including Gram-positive bacteria, Gram-negative bacteria, TB, MRSA and VRE. The addition of C. diff is expanding the range to very resistant spore producing pathogens.

Single use, pre-saturated towelettes guarantee that ALCAVIS Bleach Wipes, 1:10 Dilution are effective every time.

In the field of infection prevention, Angelini is providing healthcare professionals with a range of sanitizing and disinfectant treatment options for hands, hand held devices, surfaces, water, and medical devices.

ALCAVIS Bleach Wipes, 1:10 Dilution (product code: 09041-100) are available at

Contact ANGELINI PHARMA INC. at or 800/726-2308 for more information or to order ALCAVIS Bleach Wipes, 1:10 Dilution today.

1 From